Freenome is a biotech company revolutionizing early cancer detection with advanced blood tests and AI technology.

Freenome is a biotech company revolutionizing early cancer detection with advanced blood tests and AI technology.

Lazarus CDS leverages Artificial Intelligence to improve early cancer detection by turning a primary care doctor into a specialist for 5 minutes. For diseases like cervical cancer, this is as simple as a simple prompt that alerts physicians of high-risk patients, enabling them to make better clinical decisions. In skin cancer, we turn any mobile device into an AI-powered dermascope, automatically classifying risk based on a whole host of factors. Best of all, it's fully explainable. No black boxes, just real results.

Lazarus uses patient health data and AI to detect cancer early. The company has clinical decision support systems for skin and cervical cancer, which help improve the diagnostic accuracy of physicians.